Gene · 2017
Papers4,431
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,121 to 2,140 of 4,431
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hakai overexpression effectively induces tumour progression and metastasis in vivo. | Sci Rep | 2018 | 29472634 | PubTator, text mining | PubMed |
| Genetic populations and virulence factors of Helicobacter pylori. | Infect Genet Evol | 2018 | 29471116 | PubTator, text mining | PubMed |
| hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process. | Proc Natl Acad Sci U S A | 2018 | 29439204 | PubTator, text mining | PubMed |
| Two de novo novel mutations in one SHANK3 allele in a patient with autism and moderate intellectual disability. | Am J Med Genet A | 2018 | 29423971 | PubTator, text mining | PubMed |
| Suppression of FGFR3- and MYC-dependent oncogenesis by tubacin: association with HDAC6-dependent and independent activities. | Oncotarget | 2018 | 29423038 | PubTator, text mining | PubMed |
| ING5 differentially regulates protein lysine acetylation and promotes p300 autoacetylation. | Oncotarget | 2018 | 29416718 | PubTator, text mining | PubMed |
| Nischarin regulates focal adhesion and Invadopodia formation in breast cancer cells. | Mol Cancer | 2018 | 29415725 | PubTator, text mining | PubMed |
| Elucidating mechanistic insights into drug action for atopic dermatitis: a systems biology approach. | BMC Dermatol | 2018 | 29415693 | PubTator, text mining | PubMed |
| Mapping Interactions between p27 and RhoA that Stimulate Cell Migration. | J Mol Biol | 2018 | 29410088 | PubTator, text mining | PubMed |
| Survivin-targeting miR-542-3p overcomes HER3 signaling-induced chemoresistance and enhances the antitumor activity of paclitaxel against HER2-overexpressing breast cancer. | Cancer Lett | 2018 | 29409974 | PubTator, text mining | PubMed |
| Human papilloma virus: Apprehending the link with carcinogenesis and unveiling new research avenues (Review). | Int J Oncol | 2018 | 29393378 | PubTator, text mining | PubMed |
| Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming. | Int J Mol Sci | 2018 | 29385066 | PubTator, text mining | PubMed |
| c-Src activity is differentially required by cancer cell motility modes. | Oncogene | 2018 | 29379163 | PubTator, text mining | PubMed |
| Risk analysis of malignant potential of oral verrucous hyperplasia: A follow-up study of 269 patients and copy number variation analysis. | Head Neck | 2018 | 29377391 | PubTator, text mining | PubMed |
| Serological and experimental studies in different forms of myasthenia gravis. | Ann N Y Acad Sci | 2018 | 29377162 | PubTator, text mining | PubMed |
| Cortactin recruits FMNL2 to promote actin polymerization and endosome motility in invadopodia formation. | Cancer Lett | 2018 | 29374558 | PubTator, text mining | PubMed |
| Identification of a membrane-less compartment regulating invadosome function and motility. | Sci Rep | 2018 | 29348417 | PubTator, text mining | PubMed |
| Identification of Secreted Proteins Involved in Nonspecific dsRNA-Mediated Lutzomyia longipalpis LL5 Cell Antiviral Response. | Viruses | 2018 | 29346269 | PubTator, text mining | PubMed |
| Incorporation of iloprost in phospholipase-resistant phospholipid scaffold enhances its barrier protective effects on pulmonary endothelium. | Sci Rep | 2018 | 29343759 | PubTator, text mining | PubMed |
| The Significant Role of c-Abl Kinase in Barrier Altering Agonists-mediated Cytoskeletal Biomechanics. | Sci Rep | 2018 | 29343719 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2017/papers?page=107